Downregulation of leukocyte migration after treatment with CCR5 antagonist maraviroc

Journal of Acquired Immune Deficiency Syndromes

Volumn 54, Issue 5, 2010, Pages

  Rossi, Raffaella ^a   Lichtner, Miriam ^a   Sauzullo, Ilaria ^a   Mengoni, Fabio ^a   Marocco, Raffaella ^a   Massetti, Anna Paola ^a   Mastroianni, Claudio Maria ^a   Vullo, Vincenzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5 ANTAGONIST; MARAVIROC; RANTES;

BLOOD SAMPLING; CASE REPORT; CELL MIGRATION; CHEMOTAXIS; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INNATE IMMUNITY; LETTER; LEUKOCYTE MIGRATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TREATMENT FAILURE;

ANTI-HIV AGENTS; CELL MIGRATION ASSAYS, LEUKOCYTE; CELL MOVEMENT; CYCLOHEXANES; DOWN-REGULATION; HUMANS; IMMUNOLOGIC FACTORS; LEUKOCYTES; TRIAZOLES;

EID: 77954986491     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181ed18f6     Document Type: Letter

References (9)

1. MacArthur RD, Novak RM. Maraviroc: the first of a new class of antiretroviral agents. Clin Infect Dis. 2008;47:236-241.
2. Soriano V, Perno CF, Kaiser R, et al.When and how to use maraviroc in HIV-infected patients. AIDS. 2009;23:2377-2385.
3. Corbeau P, Reynes J. CCR5 antagonism in HIV infection: ways, effects, and side effects. AIDS. 2009;23:1931-1943.
4. Alkhatib G. The biology of CCR5 and CXCR4. Curr Opin HIV AIDS. 2009;4:96-103.
5. Lieberman-Blum SS, Fung HB, Bandres JC. Maraviroc: a CCR5-receptor antagonist for the treatment of HIV-1 infection. Clin Ther. 2008; 30:1228-1250.
6. Emmelkamp JM, Rockstroh JK. CCR5 antagonists: comparison of efficacy, side effects, pharmacokinetics and interactions-review of the literature. Eur J Med Res. 2007:12;409-417.
7. Lederman, MM, Nicholson AP, Cho M, et al. Biology and CCR5 and its role in HIV infection and treatment. JAMA. 2006;296:815-826.
8. Pett SL. Immunotherapies in HIV-1 infection. Curr Opin HIV AIDS. 2009;4:188-193.
9. Dhami H, Fritz CE, Gankin B, et al. The chemokine system and CCR5 antagonists: potential in HIV treatment and other novel therapies. J Clin Pharm Ther. 2009;34:147-160.